We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Maryanne Kline has been assisting clients through the H1B Visa process since 2020.

As of 2022, Maryanne Kline has succesfully submitted and recieved certification for 426 cases.

Maryanne Kline is located in Boston, MA, and has represented 61 employers for the H1B Visa Process

430
Cases Handled
426
Cases Certified
99.07%
Approval

Cases Handled by Maryanne Kline

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-22273-504956 Certified Chemists Research And Development In Biotechnology Except Nanobiotechnology Blueprint Medicines Corporation 2023
I-200-22196-354473 Certified Chemists Research And Development In Biotechnology Except Nanobiotechnology Blueprint Medicines Corporation 2022
I-200-22123-129803 Certified Chemists Research And Development In Biotechnology Except Nanobiotechnology Blueprint Medicines Corporation 2022
I-200-22049-915318 Certified Chemists Research And Development In Biotechnology Except Nanobiotechnology Blueprint Medicines Corporation 2022
I-200-21168-408239 Certified Chemists Research And Development In Biotechnology Except Nanobiotechnology Blueprint Medicines Corporation 2021
I-200-22220-402028 Certified Chemists Pharmaceutical And Medicine Manufacturing Kiniksa Pharmaceuticals Corp 2022
I-200-23254-336254 Certified Medical Scientists Except Epidemiologists Research And Development In Biotechnology Except Nanobiotechnology Blueprint Medicines Corporation 2023
I-200-22285-525085 Certified Medical Scientists Except Epidemiologists Research And Development In Biotechnology Except Nanobiotechnology Blueprint Medicines Corporation 2023
I-200-22208-380168 Certified Medical Scientists Except Epidemiologists Research And Development In Biotechnology Except Nanobiotechnology Blueprint Medicines Corporation 2022
I-200-22133-169304 Certified Medical Scientists Except Epidemiologists Research And Development In Biotechnology Except Nanobiotechnology Blueprint Medicines Corporation 2022